在晚期前列腺癌中,IGFBP3-SphK1/S1P信号轴驱动恩扎胺抗性
Amy R Leslie1, Shu Ning2, Masuda Sharifi1
1University of California, Davis, Sacramento, CA, United States.
Molecular cancer therapeutics
|December 5, 2025
概括
胰岛素样生长因子结合蛋白3 (IGFBP3) 通过激活SphK1/S1P通路,驱动晚期前列腺癌中的酶胺耐药性. 针对这一轴提供了一种克服治疗耐药性的新策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 恩扎胺耐药性是晚期前列腺癌治疗的一个主要障碍.
- 识别耐药性的分子机制对于治疗开发至关重要.
研究的目的:
- 确定割抵抗性前列腺癌 (CRPC) 中恩扎胺耐药性的关键分子驱动因素.
- 研究胰岛素样生长因子结合蛋白3 (IGFBP3) 在调解酶胺耐药性的作用.
- 探索向IGFBP3信号通路的治疗潜力.
主要方法:
- 在耐恩扎胺CRPC细胞系和患者样本中分析IGFBP3表达.
- 研究了IGFBP3调节 (敲击/过度表达) 对恩扎拉胺敏感性的影响.
- 检查了氨酸激酶1 (SphK1) /氨酸-1-酸盐 (S1P) 途径的激活.
- 在临床前模型中利用siRNA用于IGFBP3抑制和SKI-II作为SphK1抑制剂.
主要成果:
- 在对恩扎拉胺耐药CRPC细胞和患者样本中,IGFBP3的表达显著上调,与生存率差相关.
- 恩扎胺治疗直接诱导IGFBP3的表达.
- IGFBP3激活SphK1/S1P通路,促进细胞存活和抵抗.
- 阻断IGFBP3或抑制SphK1,使抗酶胺的抗性细胞重新敏感,并减少瘤生长.
结论:
- 在晚期前列腺癌中,IGFBP3是酶胺耐药性的关键调解者.
- IGFBP3-SphK1-S1P信号轴代表了一个新的治疗点.
- 针对这一轴有望克服CRPC患者的恩扎拉胺耐药性.
相关概念视频
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Amplifying Signals via Enzymatic Cascade
17.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


